scandenoside R1
114715-44-5
|
Notoginsenoside R3
87741-76-2
|
Vinaginsenoside R3
156012-92-9
|
LONG R3 IGF-I RECOMBINANT ANALOG
143045-27-6
|
(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpr
101849-76-7
|
Oxiranecarboxamide, 3-methyl-2-propyl-, (2R-cis)- (9CI)
200356-08-7
|
Oxiranecarboxamide, 3-methyl-2-(1-methylethyl)-, (2R,3R)- (9CI)
200356-10-1
|
R3 IGF-I
139659-92-0
|
2-Ethyl-4-fluoro-6-methylbenzylchloride
248920-25-4
|
6-Isopropyl-2,2,4-trimethyl-1H-quinoline
92728-68-2
|
5-Chloro-2,3-dihydro-imidazo[1,2-c]quinazoline
27114-98-3
|
4-(Aziridin-1-yl)-2-chloro-6,7-dimethoxyquinazoline
27631-30-7
|
4-Methoxy-2-(piperidin-1-yl)benzaldehyde
1170923-78-0
|
2,6-Dimethoxy-3,5-dimethyl-4H-pyran-4-one
21249-80-9
|
(1-(p-Tolyl)pyrrolidin-3-yl)methanol
848317-65-7
|
(1R,2R)-N1,N2-Dimethyl-N1,N2-bis(phenylmethyl)-1,2-cyclohexanediamine
644958-87-2
|
2-Bromo-5-(2,3,4,5-tetraphenylphenyl)thiophene
847196-63-8
|
N-[(2E)-3-(4-Methoxyphenyl)-1-oxo-2-propen-1-yl]benzamide
851477-26-4
|
